| نتایج یافت شده |
|
|
|
CLSI H21
|
|
2024
|
|
Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline
|
|
View Details
|
|
|
|
|
|
|
|
|
|
CLSI POCT18
|
|
|
2023
|
|
Selection Process for CLIA-Waived Testing for SARS-CoV-2, Respiratory Syncytial Virus, and Infuenza Viruses
|
|
View Details
|
|
|
|
|
|
CLSI M23
|
|
|
2023
|
|
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline
|
|
View Details
|
|
|
|
CLSI M23S3
|
|
|
2023
|
|
Procedure for Confirming the Acceptability of Mueller-Hinton Agar Sources for Subsequent Use in CLSI and/or EUCAST Studies to Establish Disk Diffusion Quality Control Ranges
|
|
View Details
|
|
|
|
CLSI EP12
|
|
|
2023
|
|
User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline
|
|
View Details
|
|
|